Ozempic and Blood Sugar: What to Know Before You Start

UK readers: mg/dL values can be converted to mmol/L by dividing by 18. HbA1c percentages appear with mmol/mol equivalents where space allows. For UK-specific guidance, Diabetes UK and NICE are reliable sources.

GLP-1 receptor agonists have become some of the most widely discussed medications in blood sugar management. Among them, Ozempic (semaglutide) has drawn significant attention from both healthcare providers and the general public. If your doctor has mentioned it, or you've simply seen the headlines, you probably have questions about how it works, what the research says, and what side effects to expect.

This guide walks through the published evidence on semaglutide and blood sugar. We'll cover the mechanism, key clinical trials, common side effects, and the questions worth asking your healthcare provider. Nothing here is medical advice. It's an educational overview to help you prepare for that conversation.

Every person's metabolic situation is different. What works well for one person may not be right for another. Your doctor is the only person who can determine whether Ozempic fits your individual health profile.

What Is Ozempic and How Does It Affect Blood Sugar?

Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist approved by the FDA in 2017 for type 2 diabetes. In the SUSTAIN trial program, semaglutide reduced A1C by 1.0-1.8 percentage points over 30-56 weeks across multiple studies and doses.^[1] That level of glucose-lowering is among the largest observed for any injectable non-insulin medication. Talk to your healthcare provider about whether this medication fits your needs.

How GLP-1 works in the body

GLP-1, or glucagon-like peptide-1, is a hormone your gut naturally releases after eating. It does three main things. First, it tells the pancreas to release more insulin when blood sugar is higher. Second, it signals the pancreas to reduce glucagon, a hormone that raises blood sugar. Third, it slows gastric emptying, meaning food leaves your stomach more gradually.^[3]

Natural GLP-1 breaks down within minutes. Semaglutide is engineered to last much longer, roughly seven days, which is why Ozempic is a once-weekly injection. The extended half-life comes from structural modifications that help it bind to albumin in the blood and resist enzymatic breakdown.^[4]

Why blood sugar drops aren't the whole story

GLP-1 receptor agonists affect more than glucose numbers. They also reduce appetite through brain signaling, which often leads to weight loss. In SUSTAIN-6, participants on the 1.0 mg dose lost an average of 4.3 kg over two years.^[5] That weight change itself may support improved insulin sensitivity in muscle and liver cells. But these are secondary effects. The primary reason doctors prescribe Ozempic is blood sugar management.

What Did the SUSTAIN Trials Actually Find?

The SUSTAIN clinical trial program included more than 8,000 participants across multiple randomized controlled trials. SUSTAIN-1 through SUSTAIN-10 tested semaglutide against placebo and active comparators at doses of 0.5 mg and 1.0 mg weekly.^[7] These trials form the foundation of what we know about Ozempic's efficacy and safety profile. Here's what the data showed.

SUSTAIN-1: semaglutide versus placebo

In SUSTAIN-1, adults with type 2 diabetes who were not on other glucose-lowering medications received semaglutide 0.5 mg, 1.0 mg, or placebo for 30 weeks. The 0.5 mg group saw an average A1C reduction of 1.45%, and the 1.0 mg group saw a 1.55% reduction, compared to 0.02% for placebo.^[8] Those are large effect sizes for a single medication.

SUSTAIN-2: added to metformin

SUSTAIN-2 compared semaglutide to sitagliptin (Januvia) in people already on metformin. After 56 weeks, semaglutide 1.0 mg reduced A1C by 1.6%, compared to 0.5% for sitagliptin.^[9] Weight loss was also greater in the semaglutide group. This trial showed semaglutide's effectiveness as an add-on to existing metformin therapy.

SUSTAIN-6: cardiovascular outcomes

SUSTAIN-6 was a two-year cardiovascular outcomes trial involving 3,297 participants with type 2 diabetes and high cardiovascular risk. Semaglutide reduced major adverse cardiovascular events (MACE) by 26% compared to placebo.^[5] This finding was significant because it showed benefits beyond blood sugar reduction. The FDA later added a cardiovascular risk reduction indication based on these results.

What Are the Common Side Effects of Ozempic?

Gastrointestinal side effects are the most frequently reported issue with semaglutide. In a pooled analysis of the SUSTAIN trials, nausea occurred in roughly 15-20% of participants, vomiting in 5-9%, and diarrhea in 8-12%.^[2] Most of these symptoms appeared during the dose-escalation phase and decreased over time. Your doctor can help manage side effects if they arise.

The dose-escalation approach

Ozempic starts at 0.25 mg weekly for the first four weeks, then increases to 0.5 mg. If needed, the dose rises to 1.0 mg after at least four more weeks. This gradual increase is designed to give the body time to adjust. Phase 3 SUSTAIN trial data show that slower titration reduces the severity of GI side effects.^[11] Some doctors extend the escalation period for patients who are more sensitive.

Less common but serious concerns

Pancreatitis has been reported in a small number of GLP-1 receptor agonist users. In SUSTAIN-6, acute pancreatitis occurred in 0.4% of the semaglutide group versus 0.2% of placebo.^[5] Semaglutide carries a boxed warning about medullary thyroid carcinoma (MTC) based on animal studies, though this hasn't been confirmed in humans. It is contraindicated in people with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2.^[12]

Hypoglycemia risk

When used alone or with metformin, semaglutide has a low risk of hypoglycemia. That's because its insulin-stimulating effect is glucose-dependent, meaning it mainly works when blood sugar is higher. However, if combined with sulfonylureas or insulin, the risk of low blood sugar increases. Your healthcare provider will likely adjust doses of those other medications if Ozempic is added.^[13]

How Does Ozempic Compare to Other Blood Sugar Medications?

Metformin remains the recommended first-line medication for most people with type 2 diabetes, according to the American Diabetes Association's 2024 Standards of Care.^[10] GLP-1 receptor agonists like semaglutide are typically considered when metformin alone isn't sufficient, or when cardiovascular or weight-related benefits are priorities. No single medication is universally best. The right choice depends on your individual profile.

Semaglutide versus other GLP-1 agonists

Semaglutide isn't the only GLP-1 receptor agonist. Others include liraglutide (Victoza), dulaglutide (Trulicity), and exenatide (Byetta/Bydureon). The SUSTAIN-7 trial compared semaglutide head-to-head against dulaglutide and found semaglutide produced greater A1C reductions (1.5-1.8% versus 1.1-1.4%) and more weight loss.^[14] But efficacy is just one factor. Cost, insurance coverage, injection frequency, and tolerability all matter when choosing a medication with your doctor.

Semaglutide versus SGLT2 inhibitors

SGLT2 inhibitors (like empagliflozin and dapagliflozin) lower blood sugar by causing the kidneys to excrete more glucose in urine. They also reduce heart failure risk. A network meta-analysis published in The Lancet Diabetes & Endocrinology found GLP-1 agonists and SGLT2 inhibitors have comparable cardiovascular benefits but work through different mechanisms.^[15] Some patients use both classes together. Ask your healthcare provider which approach fits your risk factors.

What Questions Should You Ask Your Doctor About Ozempic?

A 2019 study in Health Affairs found that the average primary care visit lasts about 18 minutes, so preparing specific questions in advance helps maximize your time.^[17] The questions below aren't exhaustive, but they cover the areas most people find useful when considering semaglutide. Your doctor's answers will depend on your full medical history, current medications, and individual goals.

Questions about suitability

• Is my A1C level appropriate for adding a GLP-1 agonist? (Most trials enrolled people with A1C between 7.0-10.5%.)
• Do I have any contraindications? These include a personal or family history of medullary thyroid cancer, pancreatitis, or severe gastrointestinal disease.
• Would a different class of medication work better for my specific situation? If you have heart failure, for example, SGLT2 inhibitors may have additional benefits.

Questions about practical use

• How long will it take to see results? Most people notice glucose changes within 1-2 weeks, with full A1C effects at 12-16 weeks.
• What should I do if I miss a dose? Novo Nordisk's prescribing information says to take the missed dose within 5 days; otherwise, skip it and resume the regular schedule.^[12]
• Will you adjust my other medications? Sulfonylurea or insulin doses often need reduction to avoid low blood sugar.

Questions about monitoring

• How often should I check my blood sugar while starting Ozempic?
• When is my next A1C test scheduled?
• What symptoms should prompt me to call you right away? (Severe abdominal pain, signs of thyroid lumps, or persistent vomiting.)

Does Lifestyle Still Matter When Taking Ozempic?

Yes. The Diabetes Prevention Program found that lifestyle changes alone reduced progression to type 2 diabetes by 58% in people with prediabetes, a figure that has held up in 15-year follow-up data.^[18] Medication and lifestyle aren't competing strategies. They're complementary. Your doctor will likely recommend continuing or starting lifestyle modifications regardless of which medications you take.

Diet and blood sugar while on semaglutide

Semaglutide slows gastric emptying, which means food sits in your stomach longer. Some people find they need smaller meals to avoid discomfort. Research in Diabetes, Obesity and Metabolism found that semaglutide users who followed a reduced-calorie diet saw more weight loss and better glucose control than those who didn't change their eating habits.^[19] A registered dietitian can help you adjust meal timing and portion sizes.

Exercise and GLP-1 therapy

Physical activity supports insulin sensitivity through pathways that don't overlap with GLP-1 signaling. A review in Sports Medicine found that aerobic and resistance training may improve insulin sensitivity for up to 48 hours after each session.^[20] That means exercise adds to semaglutide's effects rather than duplicating them. Even walking 10-15 minutes after meals has been shown to lower post-meal glucose spikes.

Sleep, stress, and the bigger picture

Sleep deprivation and chronic stress both impair insulin sensitivity independently of diet or exercise. Research in The Lancet found that sleeping only 4 hours per night for six nights reduced insulin sensitivity by roughly 40% in healthy adults.^[21] No medication fully offsets those effects. Supporting your body through good sleep hygiene and stress management may help you get the most from any glucose-lowering therapy.

What About Ozempic for Weight Loss Without Diabetes?

Semaglutide at a higher dose (2.4 mg, branded as Wegovy) is FDA-approved for chronic weight management. The STEP-1 trial found that participants without diabetes lost an average of 14.9% of their body weight over 68 weeks.^[22] This is a different indication, different dose, and different conversation with your doctor. Using Ozempic off-label for weight loss without medical supervision carries risks that may not be immediately obvious.

Why this distinction matters

Ozempic (up to 1.0 mg) is approved for type 2 diabetes. Wegovy (2.4 mg) is approved for weight management. Insurance coverage, dosing, and monitoring differ between the two. The American Medical Association has noted concerns about off-label GLP-1 use creating supply shortages for people who need these medications for diabetes management.^[23] Talk to your healthcare provider about the appropriate indication for your situation.

What Does the Long-Term Research Say?

SUSTAIN-6 provided two years of safety data, and the SELECT trial (completed in 2023) studied semaglutide 2.4 mg in over 17,600 adults with obesity and cardiovascular disease for up to five years. SELECT found a 20% reduction in major adverse cardiovascular events.^[24] These are encouraging signals, but they still represent a relatively short window for a medication many people may take for decades. Ongoing research will fill in the longer-term picture.

Durability of effects

One important finding: the STEP-1 extension study showed that when participants stopped semaglutide, they regained roughly two-thirds of the weight they had lost within a year.^[25] A1C levels also tended to drift back up. This suggests that semaglutide manages blood sugar and weight while being taken, rather than inducing permanent changes. Your doctor can discuss whether long-term use makes sense for your situation.

What researchers are still studying

Active research areas include semaglutide's effects on non-alcoholic fatty liver disease (NAFLD), kidney outcomes, and cognitive function. Early data from smaller trials suggest potential benefits in fatty liver reduction.^[26] But these areas need larger, longer studies before firm conclusions can be drawn. Science moves gradually, and that's a feature, not a bug.

Putting It All Together

Ozempic is a well-studied medication with strong clinical trial data supporting its use in type 2 diabetes blood sugar management. The SUSTAIN program showed meaningful A1C reductions, cardiovascular benefits, and a side effect profile that most people can manage with proper dose escalation. But it's not a decision to make from a blog article.

The best next step, if you're interested, is a conversation with your healthcare provider. Bring your questions. Bring your current labs. Ask about your specific risk factors, insurance coverage, and whether lifestyle changes alone might be sufficient for your goals. Informed patients tend to have better outcomes.

Blood sugar management is a long-term process, not a single decision point. Whether or not semaglutide becomes part of your plan, the fundamentals of diet, exercise, sleep, and regular monitoring remain the foundation that everything else builds on.

What Customers Tell Us

"Fasting numbers have been steadier since I added Diabec alongside my walking routine. I still see my doctor, still take my meds, this feels like a helpful addition."

"I appreciated that the label tells you what six herbs are inside and why. My GP was fine with it once she saw the ingredient list."

Individual experiences are personal reports, not typical results. Diabec is a food supplement and does not treat, cure, or prevent any disease.

Note: Semaglutide (Ozempic/Wegovy) is contraindicated in pregnancy. If you are pregnant, planning a pregnancy, or breastfeeding, discuss all medications and supplements with your healthcare provider before making any changes.

Disclaimer: These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is educational and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication.